» Articles » PMID: 32042551

Targeting YAP1/LINC00152/FSCN1 Signaling Axis Prevents the Progression of Colorectal Cancer

Overview
Journal Adv Sci (Weinh)
Date 2020 Feb 12
PMID 32042551
Citations 91
Authors
Affiliations
Soon will be listed here.
Abstract

As a transcription coactivator, Yes-associated protein 1 (YAP1)'s role in tumorigenesis is well established. However, the mechanism of YAP1-regulating long noncoding RNAs (lncRNA) in tumors is still largely unknown. Here, a YAP1 target gene, long intergenic noncoding RNA 00152 (LINC00152), which is highly expressed in colorectal cancer (CRC), is identified. The oncogenic functions of LINC00152 in CRC are demonstrated by a panel of in vitro and in vivo experiments. Further studies reveal the potential downstream mechanisms of LINC00152, which can act as a competing endogenous RNA sponging with miR-632 and miR-185-3p to regulate Fascin actin-bundling protein 1 (FSCN1) expression and thus promote the malignant proliferation and metastasis in CRC cells. Targeting the YAP1/LINC00152/FSCN1 axis inhibits the progression of CRC. This finding provides a new regulatory model of the "YAP1-lncRNA" in CRC, which gives rise to a new perspective, "YAP1/LINC00152/miR-632-miR-185-3p/FSCN1," to explore the cancer-promoting mechanism of YAP1 involved in CRC.

Citing Articles

Endometriosis and Cytoskeletal Remodeling: The Functional Role of Actin-Binding Proteins.

Arendt W, Kleszczynski K, Gagat M, Izdebska M Cells. 2025; 14(5).

PMID: 40072086 PMC: 11898689. DOI: 10.3390/cells14050360.


Impact of Maternal BPA Exposure during Pregnancy on Obesity in Male Offspring: A Mechanistic Mouse Study of Adipose-Derived Exosomal miRNA.

Huang Z, Niu R, Xu Q, Zhang R, Hu W, Qin Y Environ Health Perspect. 2025; 133(1):17011.

PMID: 39886984 PMC: 11783688. DOI: 10.1289/EHP14888.


The role of N6-methyladenosine modification in tumor angiogenesis.

Qin L, Zeng X, Qiu X, Chen X, Liu S Front Oncol. 2024; 14:1467850.

PMID: 39691597 PMC: 11649548. DOI: 10.3389/fonc.2024.1467850.


Circulating exosomal PCAT1 as a complement of carcinoembryonic antigen for early colorectal cancer diagnosis.

Cao J, Chao W, Zhang J, Mao J, Zeng J, Luo D Heliyon. 2024; 10(20):e39264.

PMID: 39640681 PMC: 11620264. DOI: 10.1016/j.heliyon.2024.e39264.


Hippo Signaling Pathway in Colorectal Cancer: Modulation by Various Signals and Therapeutic Potential.

Mohammadpour S, Torshizi Esfahani A, Sarpash S, Vakili F, Zafarjafarzadeh N, Mashaollahi A Anal Cell Pathol (Amst). 2024; 2024:5767535.

PMID: 39431199 PMC: 11489006. DOI: 10.1155/2024/5767535.


References
1.
Li J, Wang W, Chen S, Cai J, Ban Y, Peng Q . FOXA1 reprograms the TGF-β-stimulated transcriptional program from a metastasis promoter to a tumor suppressor in nasopharyngeal carcinoma. Cancer Lett. 2018; 442:1-14. DOI: 10.1016/j.canlet.2018.10.036. View

2.
Li Y, Lu J, Bao X, Wang X, Wu J, Hong W . MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1. J Exp Clin Cancer Res. 2015; 34:130. PMC: 4621856. DOI: 10.1186/s13046-015-0242-6. View

3.
Zhang X, Wei L, Wang J, Qin Z, Wang J, Lu Y . Suppression Colitis and Colitis-Associated Colon Cancer by Anti-S100a9 Antibody in Mice. Front Immunol. 2018; 8:1774. PMC: 5733461. DOI: 10.3389/fimmu.2017.01774. View

4.
Johnson R, Halder G . The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discov. 2013; 13(1):63-79. PMC: 4167640. DOI: 10.1038/nrd4161. View

5.
Yu F, Zhao B, Guan K . Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer. Cell. 2015; 163(4):811-28. PMC: 4638384. DOI: 10.1016/j.cell.2015.10.044. View